Click for best price
Hepatitis C Drugs Market Size, Share 2022
Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.
This report contains market size and forecasts of Hepatitis C Drugs in Global, including the following market information:
The global Hepatitis C Drugs market was valued at 6415.7 million in 2021 and is projected to reach US$ 7975.7 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Viral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis C Drugs include Gilead sciences, Abbvi, Johnson & Johnson, Merck, Glaxosmithkline, Novartis, Bristol-Myers Squibb and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis C Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis C Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis C Drugs Market Segment Percentages, by Type, 2021 (%)
- Anti-Viral
- Immuno-modulators
- Others
Global Hepatitis C Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis C Drugs Market Segment Percentages, by Application, 2021 (%)
Global Hepatitis C Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis C Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hepatitis C Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Hepatitis C Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Gilead sciences
- Abbvi
- Johnson & Johnson
- Merck
- Glaxosmithkline
- Novartis
- Bristol-Myers Squibb
- Roche
| Report Attributes |
Report Details |
| Report Title |
Hepatitis C Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis C Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis C Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis C Drugs Overall Market Size
2.1 Global Hepatitis C Drugs Market Size: 2021 VS 2028
2.2 Global Hepatitis C Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis C Drugs Players in Global Market
3.2 Top Global Hepatitis C Drugs Companies Ranked by Revenue
3.3 Global Hepatitis C Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis C Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis C Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis C Drugs Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis C Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis C Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hepatitis C Drugs Market Size Markets, 2021 & 2028
4.1.2 Anti-Viral
4.1.3 Immuno-modulators
4.1.4 Others
4.2 By Type - Global Hepatitis C Drugs Revenue & Forecasts
4.2.1 By Type - Global Hepatitis C Drugs Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis C Drugs Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis C Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Hepatitis C Drugs Revenue & Forecasts
5.2.1 By Application - Global Hepatitis C Drugs Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis C Drugs Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis C Drugs Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis C Drugs Revenue & Forecasts
6.2.1 By Region - Global Hepatitis C Drugs Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis C Drugs Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hepatitis C Drugs Revenue, 2017-2028
6.3.2 US Hepatitis C Drugs Market Size, 2017-2028
6.3.3 Canada Hepatitis C Drugs Market Size, 2017-2028
6.3.4 Mexico Hepatitis C Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hepatitis C Drugs Revenue, 2017-2028
6.4.2 Germany Hepatitis C Drugs Market Size, 2017-2028
6.4.3 France Hepatitis C Drugs Market Size, 2017-2028
6.4.4 U.K. Hepatitis C Drugs Market Size, 2017-2028
6.4.5 Italy Hepatitis C Drugs Market Size, 2017-2028
6.4.6 Russia Hepatitis C Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Hepatitis C Drugs Market Size, 2017-2028
6.4.8 Benelux Hepatitis C Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hepatitis C Drugs Revenue, 2017-2028
6.5.2 China Hepatitis C Drugs Market Size, 2017-2028
6.5.3 Japan Hepatitis C Drugs Market Size, 2017-2028
6.5.4 South Korea Hepatitis C Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Hepatitis C Drugs Market Size, 2017-2028
6.5.6 India Hepatitis C Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hepatitis C Drugs Revenue, 2017-2028
6.6.2 Brazil Hepatitis C Drugs Market Size, 2017-2028
6.6.3 Argentina Hepatitis C Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis C Drugs Revenue, 2017-2028
6.7.2 Turkey Hepatitis C Drugs Market Size, 2017-2028
6.7.3 Israel Hepatitis C Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Hepatitis C Drugs Market Size, 2017-2028
6.7.5 UAE Hepatitis C Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Gilead sciences
7.1.1 Gilead sciences Corporate Summary
7.1.2 Gilead sciences Business Overview
7.1.3 Gilead sciences Hepatitis C Drugs Major Product Offerings
7.1.4 Gilead sciences Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.1.5 Gilead sciences Key News
7.2 Abbvi
7.2.1 Abbvi Corporate Summary
7.2.2 Abbvi Business Overview
7.2.3 Abbvi Hepatitis C Drugs Major Product Offerings
7.2.4 Abbvi Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.2.5 Abbvi Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Hepatitis C Drugs Major Product Offerings
7.3.4 Johnson & Johnson Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Hepatitis C Drugs Major Product Offerings
7.4.4 Merck Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.4.5 Merck Key News
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Corporate Summary
7.5.2 Glaxosmithkline Business Overview
7.5.3 Glaxosmithkline Hepatitis C Drugs Major Product Offerings
7.5.4 Glaxosmithkline Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.5.5 Glaxosmithkline Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Hepatitis C Drugs Major Product Offerings
7.6.4 Novartis Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Hepatitis C Drugs Major Product Offerings
7.7.4 Bristol-Myers Squibb Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Hepatitis C Drugs Major Product Offerings
7.8.4 Roche Hepatitis C Drugs Revenue in Global Market (2017-2022)
7.8.5 Roche Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis C Drugs Market Opportunities & Trends in Global Market
Table 2. Hepatitis C Drugs Market Drivers in Global Market
Table 3. Hepatitis C Drugs Market Restraints in Global Market
Table 4. Key Players of Hepatitis C Drugs in Global Market
Table 5. Top Hepatitis C Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis C Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis C Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis C Drugs Product Type
Table 9. List of Global Tier 1 Hepatitis C Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis C Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis C Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis C Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hepatitis C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis C Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis C Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hepatitis C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis C Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis C Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Gilead sciences Corporate Summary
Table 31. Gilead sciences Hepatitis C Drugs Product Offerings
Table 32. Gilead sciences Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Abbvi Corporate Summary
Table 34. Abbvi Hepatitis C Drugs Product Offerings
Table 35. Abbvi Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Hepatitis C Drugs Product Offerings
Table 38. Johnson & Johnson Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Hepatitis C Drugs Product Offerings
Table 41. Merck Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Glaxosmithkline Corporate Summary
Table 43. Glaxosmithkline Hepatitis C Drugs Product Offerings
Table 44. Glaxosmithkline Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Hepatitis C Drugs Product Offerings
Table 47. Novartis Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Hepatitis C Drugs Product Offerings
Table 50. Bristol-Myers Squibb Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Hepatitis C Drugs Product Offerings
Table 53. Roche Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hepatitis C Drugs Segment by Type in 2021
Figure 2. Hepatitis C Drugs Segment by Application in 2021
Figure 3. Global Hepatitis C Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis C Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis C Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis C Drugs Revenue in 2021
Figure 8. By Type - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 12. US Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 24. China Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead sciences Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbvi Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glaxosmithkline Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
